309 results
Page 6 of 16
8-K
qwwrg
13 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:24pm
8-K
EX-99.1
w79eeokjz3lqnx
5 Sep 19
Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
8:20am
8-K
npy6qjgy2cz bzo6
5 Sep 19
Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
8:20am
8-K
xfk6mg2ve 4oc
30 Jul 19
Alimera Sciences Announces Second Quarter 2019 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
3qb617gcrz3i268kkjaj
30 Jul 19
Alimera Sciences Announces Second Quarter 2019 Financial Results and Provides Corporate Update
8:10am
8-K
hbdnodvwzcjerna4bi2
4 Jun 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
EX-10.58
s78n72b34
8 May 19
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.59
frcew3s va9kxugipw
8 May 19
Departure of Directors or Certain Officers
4:32pm
8-K
EX-99.1
smyj74 wdcap1
30 Apr 19
Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview
8:08am
8-K
vfcy h64nr72k9xw
30 Apr 19
Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview
8:08am
8-K
EX-99.1
i4s9iv s0p
9 Apr 19
Alimera Sciences Announces Expansion of Leadership Team with Appointment of Samer Kaba, MD as Chief Medical Officer
5:20pm
8-K
EX-99.2
jjcdkd3ntzz6nxf
19 Feb 19
Alimera Sciences Reports Record Fourth Quarter and 2018 Results
6:35am
8-K
EX-99.1
awyrqqqwdbvrj
19 Feb 19
Alimera Sciences Reports Record Fourth Quarter and 2018 Results
6:35am
8-K
dh1 0nfjozwpdsli
19 Feb 19
Alimera Sciences Reports Record Fourth Quarter and 2018 Results
6:35am
8-K
EX-99.1
x2ugp1qu1hd7n bcz8
7 Jan 19
Alimera Sciences Affirms Record 2018 Revenues
8:26am
8-K
5t3h3h kiye2fo
7 Jan 19
Alimera Sciences Affirms Record 2018 Revenues
8:26am